Miriam Hiebeler
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Successful pregnancy of an SMA type 3 sitter on Nusinersen therapy - a case report.
Journal: BMC neurology
Published: October 24, 2024
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study.
Journal: The Lancet regional health. Europe
Published: October 24, 2023
Myelitis as a side effect of tofersen therapy in SOD1-associated ALS.
Journal: Journal of neurology
Published: September 25, 2023
Time to diagnosis of Duchenne muscular dystrophy in Austria and Germany.
Journal: Scientific reports
Published: September 15, 2022
Adult Spinal Muscular Atrophy
Journal: Fortschritte der Neurologie-Psychiatrie
Published: September 14, 2022
Slowly Progressive Limb-Girdle Weakness and HyperCKemia - Limb Girdle Muscular Dystrophy or Anti-3-Hydroxy-3-Methylglutaryl-CoA-Reductase-Myopathy?
Journal: Journal of neuromuscular diseases
Published: June 27, 2022
Methylation of the 4q35 D4Z4 repeat defines disease status in facioscapulohumeral muscular dystrophy.
Journal: Brain : a journal of neurology
Published: May 13, 2022
Cutaneous T-cell lymphoma mimicking myopathy with lipoatrophy.
Journal: Neuromuscular disorders : NMD
Published: May 25, 2021
Effect of Discontinuation of Nusinersen Treatment in Long-Standing SMA3.
Journal: Journal of neuromuscular diseases
Published: March 08, 2021
Congenital myopathy and epidermolysis bullosa due to PLEC variant.
Journal: Neuromuscular disorders : NMD
Published: February 03, 2021
Safety and Treatment Effects of Nusinersen in Longstanding Adult 5q-SMA Type 3 - A Prospective Observational Study.
Journal: Journal of neuromuscular diseases
Published: October 09, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026